| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/22/2010 | WO2009158309A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 04/22/2010 | WO2009155439A3 Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| 04/22/2010 | US20100099769 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 04/22/2010 | US20100099677 Compounds, Compositions and Methods Comprising Thiazole Derivatives |
| 04/22/2010 | US20100098795 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/22/2010 | CA2740989A1 Compositions and methods for treatment of kidney disorders |
| 04/22/2010 | CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | CA2739545A1 Method of determining a phosphorus binder dosage for a dialysis patient |
| 04/22/2010 | CA2739060A1 Fused-ring derivative and medical application of same |
| 04/22/2010 | CA2739058A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
| 04/21/2010 | CN1931338B Chinese medicine for treating urinary calculus |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN1698668B Motherwort extract dispersed tablet and preparation method of motherwort extract |
| 04/21/2010 | CN101696384A Fit-keeping and health-care Chinese medicinal wine for middle and aged people |
| 04/21/2010 | CN101695560A Chinese medicinal composition for treating concrement |
| 04/21/2010 | CN101695555A Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof |
| 04/21/2010 | CN101695532A Medicament for treating prostate disease and preparation process thereof |
| 04/21/2010 | CN101695478A Tamsulosin hydrochloride sustained-release pellets and preparation method thereof |
| 04/21/2010 | CN101204517B Chinese traditional medicine for nephropathy |
| 04/20/2010 | US7700715 Kit for use in the diagnosis and treatment of cancer |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | CA2438509C Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria |
| 04/20/2010 | CA2438506C Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 04/20/2010 | CA2386826C Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for peritoneal dialysis |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/15/2010 | WO2010042626A1 1-phenylpyrrole compounds |
| 04/15/2010 | WO2010041726A1 Substituted tricyclic heteroaryl compound |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010041569A1 Indazole compound |
| 04/15/2010 | WO2010041568A1 Indazole derivative |
| 04/15/2010 | WO2010040305A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 04/15/2010 | WO2010012817A3 5ht7 receptor ligands and compositions comprising the same |
| 04/15/2010 | WO2009158487A3 Treatment of nephrolithiasis and urolithiasis using 1,2,3,4,6-penta-o-galloyl-beta-d-glucose (pgg) |
| 04/15/2010 | US20100093857 Amido-amine polymer compositions |
| 04/15/2010 | US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093790 Isoquinoline compounds |
| 04/15/2010 | US20100093740 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives |
| 04/15/2010 | US20100093701 Combination therapy comprising angiotensin receptor blockers and vasopressin receptor antagonists |
| 04/15/2010 | US20100092586 Natural water soluble extracts for the inhibition of alpha-1-adrenergic receptors |
| 04/15/2010 | US20100092559 Boldine compounds for promoting bone growth |
| 04/15/2010 | US20100092556 Alfuzosin formulations, methods of making, and methods of use |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092432 Cell preparation containing multipotential stem cells originating in fat tissue |
| 04/15/2010 | US20100092422 Poly (ß-hydroxy short-medium chain fatty acid) |
| 04/15/2010 | US20100092421 Process for the Preparation of Sevelamer Hydrochloride and Formulation Thereof |
| 04/15/2010 | CA2740772A1 Indazole compounds |
| 04/15/2010 | CA2736930A1 1-phenylpyrrole compounds |
| 04/14/2010 | EP2173773A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 04/14/2010 | EP1641473B1 Buffered compositions for dialysis |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1973864B Medicine composition for treating hematuria and nephropyelitis and its preparation |
| 04/14/2010 | CN101693090A Technology for preparing compound kidney inflammation tablets |
| 04/14/2010 | CN101693079A Traditional Chinese medicine for treating kidney disease |
| 04/14/2010 | CN101693074A Medicament for treating nephropathy |
| 04/14/2010 | CN101693051A Preparation method and composition of clerodendranthus spicatus extract |
| 04/14/2010 | CN101693050A Composition containing clerodendranthus spicatus aqueous extract |
| 04/14/2010 | CN101693045A Effective portion of conical hydrangea, preparation method thereof, and composition and usage thereof |
| 04/14/2010 | CN101254184B Salviol acid B phosphatide complexes and method of preparing the same |
| 04/14/2010 | CN101125189B Traditional Chinese medicine for curing kidney disease and its preparation method |
| 04/14/2010 | CN101040920B Drug for curing nephrosis and its preparing method |
| 04/13/2010 | US7696357 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders |
| 04/13/2010 | US7696321 Molecules and methods for inhibiting shedding of KIM-1 |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696208 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are inhibitors of VR1 expression in a cell |
| 04/13/2010 | US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7696149 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2430363C Compounds and their uses |
| 04/13/2010 | CA2395781C Detection and treatment of polycystic kidney disease |
| 04/13/2010 | CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease |
| 04/13/2010 | CA2360680C Antioxidant compositions and methods for companion animals |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/13/2010 | CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 04/09/2010 | CA2737349A1 Indazole derivatives |
| 04/08/2010 | WO2010039260A2 Spiperone derivatives and methods of treating disorders |
| 04/08/2010 | WO2010038714A1 Lactic acid bacterium having high oxalic acid decomposition ability |
| 04/08/2010 | WO2010038690A1 Controlled release pharmaceutical composition |
| 04/08/2010 | WO2010038434A1 Process for production of optically active hexahydropyrroloquinoline and intermediate for the process |
| 04/08/2010 | WO2010037284A1 Polypeptides for treating or preventing cancers, the derivative products and uses thereof |
| 04/08/2010 | WO2009122303A3 Novel mandelate salt of fesoterodine |
| 04/08/2010 | US20100087418 Benzoxazepine derivatives and use thereof |
| 04/08/2010 | CA2740342A1 Pharmaceutical composition for modified release |
| 04/08/2010 | CA2739345A1 Lactic acid bacterium having high oxalic acid decomposition ability |
| 04/07/2010 | EP2172559A1 Screening method |
| 04/07/2010 | EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor |
| 04/07/2010 | EP2172468A1 Benzimidazolone compounds |
| 04/07/2010 | EP2172458A1 Pyrazolone derivative |
| 04/07/2010 | EP2172454A1 Benzimidazole derivative |